spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  onychomycosis 

 HSMN NewsFeed - 9 Dec 2019
Moberg Pharma Meets Primary Endpoint for MOB-015 in a Phase 3 Study for the Treatment of Onychomycosis
Biopharmaceuticals
 HSMN NewsFeed - 3 Oct 2019
Turn Therapeutics(TM) Closes Series B Round to Fuel Lead Atopic Dermatitis Program Trial and Pipeline Expansion
Biopharmaceuticals Dermatology Venture Capital
 HSMN NewsFeed - 29 Oct 2018
Perrigo Confirms Patent Challenge For Generic Version Of Kerydin(R)
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 1 Oct 2018
Perrigo Confirms Patent Challenge for Generic Version of Jublia(R) Topical Solution 10%
Biopharmaceuticals Generics FDA Litigation
 HSMN NewsFeed - 16 May 2016
Pfizer to Acquire Anacor
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 12 Nov 2015
Viamet Appoints Dr. Volker Herrmann as Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Feb 2015
Galderma Announces Availability of Soolantra(R) (ivermectin) Cream, 1%
Biopharmaceuticals Dermatology FDA Product Launch
 HSMN NewsFeed - 21 Oct 2014
Viamet Announces $60 Million Series D Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 16 Sep 2014
NovaBiotics Receives Orphan Drug Status from the US Food and Drug Administration (FDA) for Lynovex(R) for the Treatment of Cystic Fibrosis
Biopharmaceuticals FDA
 HSMN NewsFeed - 21 Jul 2014
Anacor Pharmaceuticals and Sandoz Enter Into an Agreement for the Commercialization of KERYDIN in the United States
Biopharmaceuticals Dermatology Distribution
 HSMN NewsFeed - 11 Jul 2014
Ipsen and Galderma become exclusive partners for development and marketing of neurotoxins in the US, Canada, Brazil and Europe1
Biopharmaceuticals Dermatology Distribution
 HSMN NewsFeed - 26 Feb 2014
Mirvaso(R) (brimonidine) the First and Only Treatment Targeting the Facial Redness of Rosacea Approved by the European Commission
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 3 Oct 2013
Valeant Pharmaceuticals Announces Approval Of Jublia(R) For The Treatment Of Onychomycosis In Canada
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 23 Apr 2013
Nuvo Research announces European launch of Pliaglis(R) by Galderma
Biopharmaceuticals Dermatology Product Launch
 HSMN NewsFeed - 18 Mar 2013
Cynosure Signs Definitive Agreement to Acquire Palomar Medical Technologies
Devices Dermatology Mergers & Acquisitions
 HSMN NewsFeed - 12 Dec 2012
Galderma, World’s Leading Company Focused Exclusively on Dermatology, Acquires Spirig
Biopharmaceuticals Dermatology Mergers & Acquisitions
 HSMN NewsFeed - 28 Nov 2012
NanoBio(R) Closes $11 Million Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 22 Oct 2012
Nuvo and Galderma Announce FDA Approval of Pliaglis(R)
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 9 Oct 2012
NanoBio(R) Promotes David Peralta to Chief Executive Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 10 Apr 2012
Ellman International, Inc. Appoints Dave Pfeiffer as Chief Commercial Officer
Devices Personnel
 HSMN NewsFeed - 26 Mar 2012
A.P. Pharma Appoints Thomas Ottoboni, Ph.D. as Vice President of Pharmaceutical Development
Biopharmaceuticals Drug Delivery Oncology Personnel
 HSMN NewsFeed - 30 Jan 2012
Cynosure Receives FDA 510(k) Clearance for Cellulaze Cellulite Laser Workstation
Devices Dermatology FDA
 HSMN NewsFeed - 16 Dec 2011
Valeant Announces Successful Results From Phase III Onychomycosis Trials
Biopharmaceuticals
 HSMN NewsFeed - 5 Dec 2011
TOPICA Names Dr. Amir Tavakkol Senior Vice President of Clinical Development and Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Nov 2011
Viamet Pharmaceuticals Appoints Former Novartis Executive Marc Rudoltz, M.D. as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Oct 2011
Cynosure Acquires Worldwide Exclusive Rights to Distribute PinPointe(TM) FootLaser(TM) for Treatment of Onychomycosis
Devices Distribution
 HSMN NewsFeed - 28 Sep 2011
Graceway Pharmaceuticals, LLC Reaches Agreement to Sell its Assets to Galderma S.A.
Biopharmaceuticals Dermatology Acquisitions
 HSMN NewsFeed - 25 May 2011
NanoBio(R) Appoints Peter Ulrich to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Apr 2011
Anacor Pharmaceuticals Appoints William J. Rieflin to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Oct 2010
PinPointe FootLaser Receives FDA Clearance for the Treatment of Nail Fungus (Onychomycosis)
Devices FDA
 HSMN NewsFeed - 5 Oct 2010
Anacor Pharmaceuticals Appoints Geoffrey M. Parker as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Feb 2010
TOPICA Names Mark W. Davis Vice President of Clinical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Dec 2009
GlaxoSmithKline and NanoBio Announce OTC Licensing Agreement for Cold Sore Treatment
Biopharmaceuticals Licensing
 HSMN NewsFeed - 21 Sep 2009
AZZALURE(R) approved in Spain for Aesthetic Use in the Treatment of Glabellar Lines
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 25 Aug 2009
Medical Industry Veteran Bob Katz to Lead Newly Established PinPointe USA, Inc. as CEO
Devices Personnel
 HSMN NewsFeed - 8 Jul 2009
NanoBio Announces Closing of $22 Million Series B Financing Round
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 26 Jun 2009
AZZALURE(R) Approved in Germany for Aesthetic Use in the Treatment of Glabellar Lines
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 31 Mar 2009
AZZALURE( )is Approved in France for Aesthetic Use in the Treatment of Frown Lines
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 25 Mar 2009
NovaBay and Galderma Enter Into Global Agreement to Develop and Commercialize NovaBay's Novel Aganocide Drugs for Major Dermatological Conditions
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 12 Mar 2009
Ipsen: AZZALURE Approved in the UK for Aesthetic Use in the Treatment of Glabellar Lines
Biopharmaceuticals Regulatory Dermatology
 HSMN NewsFeed - 18 Feb 2009
NanoBio Corporation Raises $12 Million in Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 11 Feb 2009
HemCon Medical Technologies, Inc. Announces Further Successful Results from Live Nail Infection Anti-Fungal Study
Biopharmaceuticals
 HSMN NewsFeed - 3 Feb 2009
Warner Chilcott Announces Agreement to Acquire Topical Alprostadil Treatment for Erectile Dysfunction
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 2 Feb 2009
The Health Authorities of 15 European Countries Give a Collective Green Light to Azzalure For the Treatment of Glabellar Lines, Paving the Way for National Marketing Authorizations
Biopharmaceuticals Regulatory Dermatology
 HSMN NewsFeed - 7 Jan 2009
Nomir Medical Announces Second FDA 510(k) Clearance of its Noveon(R) Dual-Wavelength Device
Devices FDA
 HSMN NewsFeed - 6 Jan 2009
Anacor Raises $50 Million in Equity Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 3 Sep 2008
Access Pharmaceuticals Retains Piper Jaffray to Augment Strategic Partnering Efforts
Biopharmaceuticals
 HSMN NewsFeed - 20 Aug 2008
PathoLase, Inc. Appoints Skip Phairas as Chief Operating Officer
Devices Personnel
 HSMN NewsFeed - 6 Aug 2008
Stiefel Laboratories Completes Acquisition of Barrier Therapeutics
Biopharmaceuticals Dermatology Mergers & Acquisitions
 HSMN NewsFeed - 28 Jul 2008
Barrier Therapeutics Introduces Dual-Component Xolegel CorePak(TM) for Seborrheic Dermatitis
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 28 Jul 2008
Arpida Submits Marketing Authorisation Application for Intravenous Iclaprim in Europe
Biopharmaceuticals
 HSMN NewsFeed - 10 Jul 2008
Access Pharmaceuticals Signs Merger Agreement to Acquire MacroChem Corp.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 8 Jul 2008
Daniel B. Dubin, M.D., Joins NanoBio Corp.'s Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Jul 2008
Stiefel Laboratories, Inc. Commences Tender Offer to Acquire Barrier Therapeutics, Inc.
Biopharmaceuticals Dermatology Mergers & Acquisitions
 HSMN NewsFeed - 23 Jun 2008
Barrier Therapeutics, Inc. and Stiefel Laboratories, Inc. Sign Definitive Merger Agreement
Biopharmaceuticals Dermatology Mergers & Acquisitions
 HSMN NewsFeed - 23 Jun 2008
Barrier Therapeutics to Merge Into Stiefel Laboratories
Biopharmaceuticals Dermatology Mergers & Acquisitions
 HSMN NewsFeed - 22 May 2008
Barrier Therapeutics Announces Agreement with Procter & Gamble to Market Xolegel (ketoconazole, USP) Gel, 2 Percent With Head & Shoulders Shampoo as Xolegel Duo
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 16 May 2008
Nomir Medical Initiates Pivotal Trial of its Noveon(R) Dual Wave Length Device for the Treatment of Onychomycosis
Devices
 HSMN NewsFeed - 23 Apr 2008
MacroChem Acquires Virium Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 17 Apr 2008
Arpida Provides Comprehensive Overview of Pivotal Phase III Trial Data
Biopharmaceuticals
 HSMN NewsFeed - 15 Jan 2008
Talima Therapeutics Hires Martin Babler as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Dec 2007
Ipsen Grants Galderma Exclusive Rights to Promote and Distribute Dysport(R) in Aesthetic Medicine and Dermatological Indications in Brazil, Argentina and Paraguay
Biopharmaceuticals Distribution Dermatology
 HSMN NewsFeed - 20 Nov 2007
NexMed Confirms FDA Acceptance of NDA for Erectle Dysfunction Product
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 2 Nov 2007
NexMed Appoints Hem Pandya as Chief Operating Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 8 Oct 2007
GlaxoSmithKline and Anacor Pharmaceuticals Form Alliance to Develop Systemic Antivirals and Antibiotics Based on Boron Chemistry
Biopharmaceuticals
 HSMN NewsFeed - 28 Sep 2007
Barrier Therapeutics Completes Patient Enrollment for Pivotal Phase 3 Clinical Trial of Hyphanox(TM) for Onychomycosis
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 2 Aug 2007
Barrier Therapeutics Introduces New Xolegel Duo(TM) Offering at the American Academy of Dermatology (AAD) Summer Academy Meeting 2007
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 12 Jul 2007
Barrier Therapeutics Announces Positive Phase 2 Data With Oral Rambazole in Moderate to Severe Psoriasis
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 14 Jun 2007
Anacor Names Paulette Dillon as Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Jun 2007
Barrier Therapeutics Announces Liarozole Phase 2/3 Study Results in Lamellar Ichthyosis
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 29 May 2007
Talima Therapeutics Secures $19 Million Series B
Biopharmaceuticals Drug Delivery Venture Capital
 HSMN NewsFeed - 16 May 2007
Barrier Therapeutics Appoints Dr. Braham Shroot, Dermatology Expert, as New Chief Scientific Officer
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 3 May 2007
Barrier Therapeutics Receives FDA Approval for Solagé(R) Topical Solution Labeling Expansion
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 27 Mar 2007
Barrier Therapeutics Announces Azoline (Pramiconazole) Dose Ranging Study in Tinea Versicolor Meets Primary and Secondary Endpoints
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 8 Mar 2007
Barrier Therapeutics Receives Regulatory Approval to Market Xolegel(TM) in Canada
Biopharmaceuticals Regulatory Dermatology
 HSMN NewsFeed - 6 Mar 2007
Barrier Therapeutics Announces Agreement to Co-Promote Vusion(TM) Ointment to Pediatricians in the United States
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 2 Feb 2007
Schering-Plough Cites Today's Anacor Agreement as Latest in Series of Deals
Biopharmaceuticals Licensing
 HSMN NewsFeed - 2 Feb 2007
Anacor Signs Worldwide Exclusive License Agreement With Schering-Plough for AN2690, a New Topical Anti-Fungal Treatment
Biopharmaceuticals Licensing
 HSMN NewsFeed - 1 Feb 2007
Ivrea Pharmaceuticals Appoints Daniel S. Lynch as President and Chief Executive Officer
Biopharmaceuticals
 HSMN NewsFeed - 31 Jan 2007
NexMed Announces Patient Dosing in Phase 3 Program for Anti-Fungal Product
Biopharmaceuticals
 HSMN NewsFeed - 4 Dec 2006
Janus Pharmaceuticals Inc. Announces Successful Phase II Study in Shingles
Biopharmaceuticals
 HSMN NewsFeed - 27 Sep 2006
Dr. Robert C. Moellering, Jr. Joins NanoBio Corporation's Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Sep 2006
Anacor Expands Clinical Development Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Jun 2006
Transport Pharmaceuticals Names Sean Moran Chief Financial Officer
Devices Personnel
 HSMN NewsFeed - 26 Jun 2006
NexMed Announces Termination of Alprox-TD Agreement With Schering AG and Provides Operational Update
Biopharmaceuticals Drug Delivery Licensing Distribution
Return to NewsFeed  

 Additional items found! 30

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 30 additional stories matching:
onychomycosis
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.